UNSPSC 51141564: Nonapyrimine

This classification denotes an anticonvulsant agent with the molecular formula C15H24N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 322D5Y3Q0G, chemically known as 7h-pyrrolo(2,3-d)pyrimidine, 4-(nonylamino)- but generally known as nonapyrimine, which bears US NIH Compound Identifier 3047795. European Medicines Agency schedules Nonapyrimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09350MIG.

UNSPSC 51141564 Nonapyrimine is a Commodity code under which state and local governments procure pharmaceutical and medical countermeasures, specifically opioid antagonists and drug deactivation systems for public health and community safety initiatives. The work solicited under this code involves the supply and delivery of naloxone units and associated drug deactivation systems to support emergency response and harm-reduction programs operated by county health departments and related public agencies. Issuing bodies are typically county health authorities and public safety departments managing opioid response and community health infrastructure.

Seminole County, Florida solicited under this code via IFB 60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, at 2:00 pm. The procurement required quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping costs, drug-free workplace certification, E-Verify compliance, and standard commercial insurance including workers' compensation and general liability. The contract term was two years with a one-year renewal option and included a three-month probationary termination clause. The solicitation notes indicate potential FEMA funding with attendant federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.